• Jaime Latour-Pérez, Adoración Alcalá-López, Miguel-Angel García-García, José F Sánchez-Hernández, Carmen Abad-Terrado, José A Viedma-Contreras, Mar Masiá, Matilde González-Tejera, David Arizo-León, María-Jesús Broch Porcar, Fernando Bonilla-Rovira, and Félix Gutiérrez.
• Hospital General Universitario de Elche, Servicio de Medicina Intensiva, Camí Vell de l'Almàssera 11, 03203 Elche, Spain. jlatour@coma.es
• Clin. Biochem. 2010 Jun 1;43(9):720-4.

ObjectivesTo assess the accuracy of plasma levels of soluble Triggering Receptor Expressed on Myeloid cells (sTREM)-1 to diagnose infection in critical patients with systemic inflammatory response syndrome (SIRS).Design And MethodsWe prospectively studied 114 patients with SIRS criteria. The patients' plasma levels of sTREM-1 were measured within 24h of admission to the intensive care unit. The final diagnosis of infection was made independently by two investigators, who were blinded to the levels of sTREM-1.ResultsThe area under the ROC curve of sTREM-1 for the diagnosis of sepsis was 0.62 (95% confidence interval [95% CI] 0.51-0.72). The diagnostic odds ratio of sTREM-1 after adjusting for the Infection Probability Score and procalcitonin plasma levels was 1.81 (95% CI 0.66-4.98; p=0.2508).ConclusionsIn critical patients admitted with SIRS, sTREM-1 has poor discriminative power to identify patients with infection, and sTREM-1 levels do not add diagnostic information to that provided by other routinely available clinical tests.2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

19 keywords...

hide…